Results 201 to 210 of about 2,534,031 (236)

Erythema multiforme, Stevens‐Johnson syndrome/toxic epidermal necrolysis – diagnosis and treatment

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020
Prior to the first international consensus classification published in 1993, the clinical distinction between erythema multiforme (EM), Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) had been subject to uncertainty and controversy ...
P. Grünwald, M. Mockenhaupt, R. Panzer, S. Emmert   +3 more
semanticscholar   +1 more source

Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review

Journal of dermatological treatment (Print), 2020
Background: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN) is one of severe cutaneous adverse reactions with low morbidity but high mortality.
Shan Zhang, Shunli Tang, Sheng Li, Yunlei Pan, Ying-guo Ding   +4 more
semanticscholar   +1 more source

Systemic therapies for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN‐based systematic review and meta‐analysis

Journal of the European Academy of Dermatology and Venereology, 2020
The SCORTEN score is a specific predictor of mortality for patients with Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). There is little evidence in support of the common immunomodulating therapies for SJS/TEN.
I. Torres‐Navarro, Álvaro Briz-Redón, R. Botella‐Estrada, R. Botella‐Estrada   +3 more
semanticscholar   +1 more source

The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.

Journal of dermatological science (Amsterdam), 2020
BACKGROUND Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening severe cutaneous adverse reactions (SCARs). The first national epidemiological survey of SJS/TEN was carried out in 2008.
Yuma Sunaga, M. Kurosawa, H. Ochiai, H. Watanabe, H. Sueki, H. Azukizawa, H. Asada, Y. Watanabe, Y. Yamaguchi, M. Aihara, Y. Mizukawa, M. Ohyama, N. Hama, R. Abe, H. Hashizume, Saeko Nakajima, T. Nomura, K. Kabashima, M. Tohyama, Hayato Takahashi, H. Mieno, M. Ueta, C. Sotozono, H. Niihara, E. Morita, A. Kokaze   +25 more
semanticscholar   +1 more source

Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis

Acta bio-medica : Atenei Parmensis, 2019
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be considered a late-onset allergic reaction, can cause serious long-term sequelae. SJS/TEN are considered a spectrum of life-threatening adverse drug reactions. They have the
Liotti Lucia, Caimmi Silvia, Botta Paolo, Bernardini Roberto, Cardinale Fabio, Saretta Francesca, Mori Francesca, Crisafulli Giuseppe, Franceschini Fabrizio, Caffarelli Carlo   +9 more
semanticscholar   +1 more source

Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Clinical Dermatology, 2020
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, immunologically mediated cutaneous adverse reaction characterized by mucous membrane and epidermal detachment, with a mortality ranging from 15% to 25%.
M. Noe, R. Micheletti
semanticscholar   +1 more source

Incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) in France during 2003–16: a four‐source capture–recapture estimate

British Journal of Dermatology, 2020
Because of its rarity, the exact incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) is difficult to establish and closely depends on the size and type of the data source.
G. Chaby, C. Maldini, C. Haddad, B. Lebrun-Vignes, F. Hemery, S. Ingen‐Housz‐Oro, S. Gonzalez-Chiappe, P. Wolkenstein, O. Chosidow, O. Chosidow, A. Mahr, L. Fardet   +11 more
semanticscholar   +1 more source

Stevens‐Johnson syndrome and toxic epidermal necrolysis‐like reactions to checkpoint inhibitors: a systematic review

International Journal of Dermatology, 2020
The use of checkpoint inhibitors for treatment of advanced malignancies is increasing. Rashes, pruritus, and more rarely, reactions resembling Stevens‐Johnsons syndrome (SJS) or toxic epidermal necrolysis (TEN) may occur secondary to checkpoint ...
N. Maloney, Vignesh Ravi, K. Cheng, Daniel Q. Bach, S. Worswick   +4 more
semanticscholar   +1 more source

Trends in mortality rates for Stevens–Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017

British Journal of Dermatology, 2019
Epidermal necrolysis (EN), the spectrum including Stevens-Johnson syndrome (SJS, detached-detachable body surface area [BSA]
T. Bettuzzi, L. Penso, N. Prost, F. Hemery, C. Hua, A. Colin, A. Mekontso-Dessap, L. Fardet, O. Chosidow, P. Wolkenstein, É. Sbidian, S. Ingen-Housz-Oro   +11 more
semanticscholar   +1 more source

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Archives of Dermatology, 1993
S. Bastuji‐Garin, B. Rzany, R. Stern, N. Shear, L. Naldi, J. Roujeau   +5 more
semanticscholar   +1 more source